Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful ...

Almirall has completed the decentralized EU regulatory procedure for efinaconazole (Jublia) for onychomycosis. The final step ...

Almirall has completed the decentralised European regulatory procedure for efinaconazole, a triazole antifungal substance ...

Efinaconazole is a triazole antifungal compound indicated for the treatment of onychomycosis, a persistent and difficult to treat fungal infection of the nail The completion of the decentralized ...

The low binding affinity of efinaconazole topical to keratin, the main component of nails, allows high nail-penetrating properties supporting strong efficacy. With the addition of this treatment ...

S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the decentralized regulatory procedure in Europe for efinaconazole ...

Clarivate Plc , a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureatestm program, following the accurate forecast of eight Nobel Prize ...

MedPro will provide national sales coverage on behalf of Oakworks Medical, actively selling in the acute, non-acute and government markets. Oakworks Medical products are proudly made in their 91,000 ...